Jonathan J. Darrow, JD, LLM (waived), SJD, MBA
Research Fellow, Harvard Medical School
Lecturer on Law, Bentley University
Resident Tutor, Harvard College
Clerk to the Hon. Evan J. Wallach, U.S. Court of Appeals for the Federal Circuit (2014-2016)
jdarrow at sjd.law.harvard.edu
“Pharmaceutical Efficacy: History and Regulation”
The dissertation challenges the prevailing view that modern drugs are not only highly effective, but also entirely different in kind from those of the past. The long history of pharmaceutical efficacy and regulation is explored, and parallels with the present are highlighted whenever possible. Both the efficacy levels of modern drugs and the current legal standard for efficacy are critically examined. The dissertation concludes by explaining why pharmaceutical gatekeepers such as the USPTO, FDA, doctors, insurance companies, and others fail to protect the public from disappointingly effective drugs.
Harvard Law School:
William W. Fisher III (Principal Faculty Supervisor)
Benjamin N. Roin
Peter Barton Hutt
Harvard Medical School:
Aaron S. Kesselheim
- Pharmaceutical Law & Policy
- Intellectual Property Law (especially patent and copyright)
- Internet Law
- Harvard Law School, S.J.D.
- Harvard Law School, LL.M. (waived upon admission to S.J.D. program)
- Boston College, M.B.A.
- Duke Law School, J.D.
- Cornell University, B.S.
- 2013- Harvard Medical School Research Fellow
- 2006- Bentley University Sr. Research Consultant, Lecturer
- 2012-2013 Harvard Law School Petrie-Flom Student Fellow
- 2009-2012 Harvard Law School Graduate Program Fellow, LL.M. Advisor
- 2011 Cravath International Summer Fellow
- 2006-2009 Plymouth State Univ. Assistant Professor of Business Law
- 2005-2006 Boston College Adjunct Lecturer of Business Law
- Cyberlaw: Text and Cases (Cengage 2012).
Chapter 4: Trademarks
Chapter 5: Copyrights
Chapter 6: Patents
Chapter 7: Trade Secrets
- The Legal Environment of Business and Ethics: An Integrated Approach (Wolters Kluwer) (forthcoming).
Chapter 3: Administrative Law
Chapter 8: Intellectual Property Law
Chapter 11: Antitrust Law
- Jonathan J. Darrow, Crowdsourcing Clinical Trials, Minnesota Law Review (forthcoming 2014).
- Jonathan J. Darrow, Pharmaceutical Gatekeepers, Indiana Law Review (forthcoming 2014).
- Donald W. Light, Joel Lexchin & Jonathan J. Darrow, Institutional Corruption of Pharmaceuticals and the Consequences for Patients, 41(3) Journal of Law, Medicine & Ethics (forthcoming 2013).
- Dipika Jain & Jonathan J. Darrow, An Exploration of Compulsory Licensing as an Effective Policy Tool, Health Matrix (forthcoming 2013).
- Jonathan J. Darrow, Essential Medicines: Why International Price Discrimination May Increasingly Be the Wrong Solution to a Global Drug Problem, 39 Journal of Law, Medicine & Ethics 291 (2011).
- Jonathan J. Darrow,Secondary Considerations: A Structured Framework for Patent Analysis, 74 Albany Law Review 47 (2011).
- Stephen M. Darrow & Jonathan J. Darrow,Beating the Bluebook Blues: A Response to Judge Posner, 109 Michigan Law Review First Impressions (2011).
- Jonathan J. Darrow,The Neglected Dimension of Patent Law’s PHOSITA Standard, 23 Harvard Journal of Law and Technology 227(2009).
- Jonathan J. Darrow & Stephen D. Lichtenstein,“Do You Really Need My Social Security Number?” Information Collection Practices in the Digital Age, 10 North Carolina Journal of Law And Technology 1 (2008).
- Jonathan J. Darrow,The Patentability of Enantiomers: Implications for the Pharmaceutical Industry, 2007 Stanford Technology Law Review 2 (2007).
Reprinted in: Nonobviousness and Patents: Issues and Implications (C. Srikrishna ed., Icfai Univ. Press 2008).
- Jonathan J. Darrow & Gerald R. Ferrera,The Search Engine Advertising Market: Lucrative Space or Trademark Liability?, 17 Texas Intellectual Property Law Journal 223 (2009).
- Jonathan J. Darrow & Gerald R. Ferrera,Social Networking Web Sites and the Digital Millennium Copyright Act: A Safe-Harbor from Copyright Infringement Liability or the Perfect Storm? 6 Northwestern Journal of Technology & Intellectual Property 1 (2007).
- Jonathan J. Darrow & Gerald R. Ferrera,Who Owns a Decedent’s E-Mails? Inheritable Probate Assets or Property of the Network?, 10 NYU Journal of Legislation & Public Policy 281 (2007).
Adapted as: Jonathan J, Darrow & Gerald R. Ferrera, Email is Forever…Or Is It?, 11 No. 10 Journal of Internet Law 1
- Christine Neylon O’Brien & Jonathan J. Darrow,Adverse Employment Consequences Triggered by Criminal Convictions: Recent Cases Interpret State Statutes Prohibiting Discrimination, 42 Wake Forest Law Review 991 (2007).
- Stephen D. Lichtenstein & Jonathan J. Darrow,Employment Termination for Employee Blogging: Number 1 Tech Trend for 2005 and Beyond, or a Recipe for Getting Dooced?, 2006 UCLA Journal of Law & Technology 4.
Reprinted in: Blogging: Employer and Employee Conflicts (M.N. Bhavani ed., Icfai Univ. Press 2009).
Adapted as: Stephen D. Lichtenstein & Jonathan J. Darrow, At-Will Employment: A Right to Blog or a Right to
Terminate?, 11 No. 9 Journal of Internet Law 1 (2008).
- Christine Neylon O’Brien & Jonathan J. Darrow, The Question Remains After Raytheon Co. v. Hernandez: Whether No-Rehire Rules Disparately Impact Alcoholics and Former Drug Abusers, 7 University of Pennsylvania Journal of Labor & Employment Law 157 (2004).
SHORTER WORKS (selected)
- Jonathan J. Darrow, Xolair for Chronic Itch: Magic Bullet or Marketing Hype?, Bill of Health (Harvard Law School), Feb. 28, 2013.
- Jonathan J. Darrow, The High Cost of Health Care: Why Some Pay $240 for a $9 Bottle of Pills, Bill of Health (Harvard Law School), Feb. 15, 2013.
- Jonathan J. Darrow, At $28,000 a Dose, How Effective is Acthar?, Bill of Health (Harvard Law School), Jan. 8, 2013.
- Jonathan J. Darrow,S.J.D.? What’s That?, 131(6) Harvard Law Record 6 (2011).
Also published as: Jonathan J. Darrow, S.J.D.? What’s That?: A Brief History of an Overlooked, Mysterious Degree,
Georgetown Law Weekly, Mar. 29, 2011.
- Jonathan J. Darrow,Debunking the “Evergreening” Patents Myth, 131(3) Harvard Law Record 6 (2010).
- World Health Organization, IP and Public Health Considerations: Issues and Challenges, Geneva, Switzerland, July 4, 2012.
- World Trade Organization, The Nine Challenges of Pharmaceutical Price Discrimination, Geneva, Switzerland, July 28, 2011
- Testimony on Senate Bill 754 (“For Legislation to Allow Access to a Decedent’s Electronic Mail Accounts”) Before the Mass. Joint Committee on the Judiciary, May 18, 2011.
- Harvard Law School, Harvard African Law Association, Access to Medicines and Human Rights: African Perspectives, March 10, 2010.
- Northwestern University School of Law, Third Annual Symposium of the Northwestern Journal of Technology & Intellectual Property, April 18, 2008.
Last Updated: May 28, 2013